Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

285 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Active, not recruiting

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

NCT04158934

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UF Health Shands Hospital Gainesville, Florida, United States
  • SHAT of Oncohaematology Diseases Sofia, Bulgaria
  • Clinical Hospital Sveti Duh Zagreb, Croatia
  • University hospital centre Zagreb Zagreb, Croatia
View all 36 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

NCT05911763

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Banner MD Anderson Cancer Center- Site Number : 8400008 Gilbert, Arizona, United States
  • Loma Linda University- Site Number : 8400015 Loma Linda, California, United States
  • Orthopedic Institute for Children- Site Number : 8400004 Los Angeles, California, United States
  • The Center for Inherited Blood Disorders- Site Number : 8400001 Orange, California, United States
View all 28 locations
View Trial Details
Active, not recruiting

A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A

NCT06185335

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Russia
  • State budgetary healthcare institution Leningrad Regional Clinical Hospital Gatchina, Russia
  • Kuzbass Clinical Hospital named after S.V. Belyaev Kemerovo, Russia
  • Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency" Kirov, Russia
View all 17 locations
View Trial Details
Active, not recruiting

Gene Therapy for Haemophilia A.

NCT03001830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • St. Luke'S Regional Medical Center, Ltd Boise, Idaho, United States
  • University of Kentucky Lexington, Kentucky, United States
  • St Jude's Children's Research Hospital Memphis, Tennessee, United States
  • Royal Free Hospital London, United Kingdom
View Trial Details
Active, not recruiting

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

NCT03432520

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
  • Truman Medical Centers Kansas City, Missouri, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

NCT03588299

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital - Hematology / Oncology Little Rock, Arkansas, United States
  • C.S. Mott Children's Hospital - Hematology / Oncology Ann Arbor, Michigan, United States
  • UW Health Carbone Cancer Center Madison, Wisconsin, United States
  • SHATHD Spec. Hospi. for Active Treatm. of Haematol. Dis. EAD Sofia, Sofia City Province, Bulgaria
View all 13 locations
View Trial Details
Completed

A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health

NCT04293523

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Ostrava Ostrava, Czechia
  • Dept. of Pediatric Haematology and Oncology, University Hospital Motol Prague, Czechia
  • Lastehaigla, Tallinn (Tallinn Children´s Hospital) Tallinn, Estonia
View all 53 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

NCT04158648

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Childrens Hospital LA Los Angeles, California, United States
  • Hemophilia of Georgia Center for Bleeding & Clotting Disorders Atlanta, Georgia, United States
  • Indiana Hemophilia & Thrombosis center Indianapolis, Indiana, United States
  • University of Michigan, C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
View all 22 locations
View Trial Details

Related conditions